MedTrace Logo

SierraSil Joint Formula 14 as an Ergogenic Aid to Performance in Athletes

NCT01932281 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2015-07-15

No results posted yet for this study

Summary

The purpose of this study is to examine whether supplementation with SierraSil can improve anaerobic power and reduce muscle fatigue in a group of well-trained athletes.

A secondary purpose is to examine the effect of SierraSil on the severity of delayed onset muscle soreness.

Conditions

  • Muscle Power
  • Muscle Fatigue

Interventions

DIETARY_SUPPLEMENT

SierraSil

SierraSil is a natural, mineral supplement currently used to improve joint health and function.

DIETARY_SUPPLEMENT

Placebo

Sugar pill manufactured to mimic SierraSil 667 mg capsule

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Donald C. McKenzie, MD, PhD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01932281 on ClinicalTrials.gov